Stockscreener 앱 받기
26.10
1.40%
0.47
전일 마감가:
$25.63
열려 있는:
$25.57
하루 거래량:
4.06M
Relative Volume:
1.03
시가총액:
$4.69B
수익:
$644.86M
순이익/손실:
$196.05M
주가수익비율:
26.60
EPS:
0.9812
순현금흐름:
$317.50M
1주 성능:
+18.73%
1개월 성능:
+19.38%
6개월 성능:
+0.12%
1년 성능:
-57.97%
1일 변동 폭
$25.25
$26.94
1주일 범위
$19.88
$40.00
52주 변동 폭
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
명칭
Doximity Inc
전화
(650) 549-4330
주소
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, TXG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
26.09 | 3.77B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
236.88 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
57.80 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
55.35 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
105.59 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
60.02 | 5.83B | 638.78M | -22.66M | 122.18M | -0.1744 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-20 | 다운그레이드 | Truist | Buy → Hold |
| 2026-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2026-02-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2026-01-20 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | 개시 | RBC Capital Mkts | Outperform |
| 2026-01-08 | 업그레이드 | Truist | Hold → Buy |
| 2025-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-10-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-10-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-07-09 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-06-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-02-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-11-14 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-09 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-18 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2024-01-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-08-09 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 개시 | Wells Fargo | Overweight |
| 2022-10-24 | 개시 | Evercore ISI | In-line |
| 2022-10-13 | 개시 | BTIG Research | Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 개시 | Berenberg | Buy |
| 2022-05-18 | 재확인 | BofA Securities | Neutral |
| 2022-05-18 | 재확인 | Goldman | Buy |
| 2022-05-18 | 재확인 | Guggenheim | Buy |
| 2022-05-18 | 재확인 | Jefferies | Buy |
| 2022-05-18 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 재확인 | Needham | Buy |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-04 | 개시 | BofA Securities | Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-11-10 | 재확인 | Canaccord Genuity | Buy |
| 2021-11-10 | 재확인 | Goldman | Neutral |
| 2021-11-10 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 재확인 | Needham | Buy |
| 2021-11-10 | 재확인 | Piper Sandler | Overweight |
| 2021-08-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 개시 | Canaccord Genuity | Buy |
| 2021-07-19 | 개시 | Goldman | Neutral |
| 2021-07-19 | 개시 | JP Morgan | Overweight |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | Raymond James | Outperform |
| 2021-07-19 | 개시 | SVB Leerink | Outperform |
| 2021-07-19 | 개시 | William Blair | Outperform |
모두보기
Doximity Inc 주식(DOCS)의 최신 뉴스
DOCS|Doximity Inc|Price:20.974|Chg%:+0.553 - TradingKey
Doximity (DOCS) Laps the Stock Market: Here's Why - Yahoo Finance
Renaissance Technologies LLC Has $71.29 Million Stock Position in Doximity, Inc. $DOCS - MarketBeat
Bank of Nova Scotia Takes Position in Doximity, Inc. $DOCS - MarketBeat
DOCS|Doximity Inc|Price:21.170|Chg%:+0.180 - TradingKey
Caxton Associates LLP Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Doximity Inc (DOCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TradingKey - TradingKey
Doximity Inc (DOCS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Doximity Inc (DOCS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Doximity Inc (DOCS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Doximity, Inc. Revenue Breakdown – NYSE:DOCS - TradingView
Form 4 Doximity Inc For: 24 July By Investing.com - Investing.com Nigeria
Doximity, Inc. (DOCS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Doximity Inc (DOCS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Doximity, Inc. (DOCS) Options Chain - Yahoo! Finance Canada
Doximity, Inc. (DOCS) stock price, news, quote and history - Yahoo Finance Australia
Doximity, Inc. (DOCS) Latest Stock News & Headlines - Yahoo! Finance Canada
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
2 Reasons to Like DOCS (and 1 Not So Much) - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Evercore Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $22 - Moomoo
Doximity Chief Accounting Officer Sitaram Siddharth disposes of 1,732 shares worth $38,150.64 - Bitget
Sparta 24 Ltd. Takes $2.94 Million Position in Doximity, Inc. $DOCS - MarketBeat
How Doximity Inc. Class A (DOCS) Affects Rotational Strategy Timing - Stock Traders Daily
A Look at Doximity Inc (DOCS) After 3.1% Decline -- GF Value $49 - GuruFocus
Zoom, AppLovin, and Doximity Shares Are Falling, What You Need To Know - Yahoo Finance
Doximity (DOCS) Declines More Than Market: Some Information for Investors - Yahoo Finance
Reasons to Retain Doximity Stock in Your Portfolio for Now - Yahoo Finance
Is AI ready to take over your prescriptions? Doctors are wary of Utah's automated refill program - AOL.com
Is Doximity (DOCS) Cheap As Its Clinical AI Tool Tops Safety Benchmark? - Sahm
AI has taken over prescription refills in Utah. Some doctors are wary - AOL.com
Medical watchdog reveals issues with recent medical student reports - AOL.com
Press Release: Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026 - Moomoo
Doximity to report fiscal Q1 2027 results on August 6 - scanx.trade
Doximity Sets Aug. 6 Webcast to Discuss Its June Quarter - Stock Titan
Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026 - Yahoo Finance
Doximity, Inc. ($DOCS) CEO 2026 Pay Revealed - Quiver Quantitative
DOCS (NYSE: DOCS) files Form 144 for 1,732-share sale - Stock Titan
Doximity (NYSE:DOCS) Attracts Renewed Market Interest - Kalkine Media
Doximity Outranks OpenEvidence, Frontier Models in Independent S - GuruFocus
11,000 Physician Experts Helped Improve Doximity's Clinical AI - Stock Titan
Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety - Mid Florida Newspapers
Form DEF 14A Doximity For: 15 July By Investing.com - Investing.com Nigeria
Doximity | DEF 14A: Definitive information statements - Moomoo
Doximity (NYSE: DOCS) sets 2026 virtual meeting, pay and auditor votes - Stock Titan
Doximity (NYSE:DOCS) Upgraded at Zacks Research - MarketBeat
Doximity, Inc. SEC Filing (Jul 15, 2026) - Stock Titan
Form 4 Doximity Inc For: 14 July By Investing.com - Investing.com Nigeria
Doximity (DOCS) director receives 9,750 RSUs as committee voids part of prior grant - Stock Titan
Equity grant: Doximity (NYSE: DOCS) gives 21,314 RSUs to director - Stock Titan
Doximity Inc (DOCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Doximity Inc 주식 (DOCS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sitaram Siddharth | Chief Accounting Officer |
Jul 15 '26 |
Sale |
22.02 |
1,732 |
38,139 |
93,774 |
0.85%
0.78%
자본화:
|
볼륨(24시간):